These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1159 related items for PubMed ID: 31046570

  • 1. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z, El Anbari M, Anwar S, Mortimer A, Marr N, Karim MY.
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [Abstract] [Full Text] [Related]

  • 2. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
    Puapatanakul P, Chansritrakul S, Susantitaphong P, Ueaphongsukkit T, Eiam-Ong S, Praditpornsilpa K, Kittanamongkolchai W, Avihingsanon Y.
    Int J Mol Sci; 2019 Oct 08; 20(19):. PubMed ID: 31597273
    [Abstract] [Full Text] [Related]

  • 3. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
    Abujam B, Cheekatla S, Aggarwal A.
    Lupus; 2013 May 08; 22(6):614-23. PubMed ID: 23629827
    [Abstract] [Full Text] [Related]

  • 4. Value of sTNF-R1 and linc0597 as indicators for disease activity and diagnosis of lupus nephritis.
    Zheng CZ, Yan WW, Luo YL, Wang TL, Shu YB.
    Eur Rev Med Pharmacol Sci; 2020 May 08; 24(10):5582-5591. PubMed ID: 32495893
    [Abstract] [Full Text] [Related]

  • 5. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
    Mok CC, Soliman S, Ho LY, Mohamed FA, Mohamed FI, Mohan C.
    Arthritis Res Ther; 2018 Jan 11; 20(1):6. PubMed ID: 29325582
    [Abstract] [Full Text] [Related]

  • 6. Serum and Urinary Interferon-Gamma-Inducible Protein 10 in Lupus Nephritis.
    El-Gohary A, Hegazy A, Abbas M, Kamel N, Nasef SI.
    J Clin Lab Anal; 2016 Nov 11; 30(6):1135-1138. PubMed ID: 27184880
    [Abstract] [Full Text] [Related]

  • 7. Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study.
    Živković V, Cvetković T, Mitić B, Stamenković B, Stojanović S, Radovanović-Dinić B, Jurišić V.
    Rheumatol Int; 2018 Jun 11; 38(6):1003-1008. PubMed ID: 29181621
    [Abstract] [Full Text] [Related]

  • 8. Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.
    Zhang CX, Cai L, Shao K, Wu J, Zhou W, Cao LF, Chen TX.
    Pediatr Nephrol; 2018 May 11; 33(5):837-845. PubMed ID: 29264699
    [Abstract] [Full Text] [Related]

  • 9. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
    Turnier JL, Fall N, Thornton S, Witte D, Bennett MR, Appenzeller S, Klein-Gitelman MS, Grom AA, Brunner HI.
    Arthritis Res Ther; 2017 Oct 24; 19(1):242. PubMed ID: 29065913
    [Abstract] [Full Text] [Related]

  • 10. Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.
    Kiani AN, Johnson K, Chen C, Diehl E, Hu H, Vasudevan G, Singh S, Magder LS, Knechtle SJ, Petri M.
    J Rheumatol; 2009 Oct 24; 36(10):2224-30. PubMed ID: 19648301
    [Abstract] [Full Text] [Related]

  • 11. Combined detection of uMCP-1 and uTWEAK for rapid discrimination of severe lupus nephritis.
    Dong XW, Zheng ZH, Ding J, Luo X, Li ZQ, Li Y, Rong MY, Fu YL, Shi JH, Yu LC, Wu ZB, Zhu P.
    Lupus; 2018 May 24; 27(6):971-981. PubMed ID: 29451067
    [Abstract] [Full Text] [Related]

  • 12. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA, Haque A, Vanarsa K, Zhang T, Ismail F, Lee KH, Pedroza C, Greenbaum LA, Mason S, Hicks MJ, Wenderfer SE, Mohan C.
    Front Immunol; 2022 May 24; 13():885307. PubMed ID: 35720325
    [Abstract] [Full Text] [Related]

  • 13. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
    Gómez-Puerta JA, Ortiz-Reyes B, Urrego T, Vanegas-García AL, Muñoz CH, González LA, Cervera R, Vásquez G.
    Lupus; 2018 Apr 24; 27(4):637-646. PubMed ID: 29073812
    [Abstract] [Full Text] [Related]

  • 14. Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.
    Choe JY, Kim SK.
    Inflamm Res; 2016 Jun 24; 65(6):479-88. PubMed ID: 26921306
    [Abstract] [Full Text] [Related]

  • 15. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
    Hafez EA, Hassan SAE, Teama MAM, Badr FM.
    Lupus; 2021 Mar 24; 30(3):378-384. PubMed ID: 33323012
    [Abstract] [Full Text] [Related]

  • 16. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
    Abdulahad DA, Westra J, Bijzet J, Dolff S, van Dijk MC, Limburg PC, Kallenberg CG, Bijl M.
    Arthritis Res Ther; 2012 Aug 14; 14(4):R184. PubMed ID: 22892043
    [Abstract] [Full Text] [Related]

  • 17. Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis.
    Xue J, Yang J, Yang L, Zhou S, Ji C, Wang X, Yu N, Liu X, Chi S.
    J Immunol Res; 2017 Aug 14; 2017():6861575. PubMed ID: 28373995
    [Abstract] [Full Text] [Related]

  • 18. Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
    Alzawawy A, Zohary M, Ablordiny M, Eldalie M.
    Int J Rheum Dis; 2009 Dec 14; 12(4):311-8. PubMed ID: 20374368
    [Abstract] [Full Text] [Related]

  • 19. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
    Mirioglu S, Cinar S, Yazici H, Ozluk Y, Kilicaslan I, Gul A, Ocal L, Inanc M, Artim-Esen B.
    Lupus; 2020 Apr 14; 29(4):379-388. PubMed ID: 32041504
    [Abstract] [Full Text] [Related]

  • 20. A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment.
    Davies JC, Carlsson E, Midgley A, Smith EMD, Bruce IN, Beresford MW, Hedrich CM, BILAG-BR and MRC MASTERPLANS Consortia.
    Rheumatology (Oxford); 2021 Aug 02; 60(8):3747-3759. PubMed ID: 33313921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.